AMGN

Nasdaq

AMGEN INC

Latest disclosureAugust 13, 2026

Insider score Why 0?: 0/ 100
Qualifying buys · 30d: $0

0 purchases · 7 sales

Price by TradingView

Insider transactions 99

Limited filing history

Filters

Last 30 daysNo qualifying insider buying. No qualifying insider sales.

Showing the first 6 of 20 trades on this page.

Exercise or conversion

Rachna Khosla

SVP, Business Development

Common Stock

Value context: $203.58K
Reported price: $162.60 / share

Exercise or conversion

Rachna Khosla

SVP, Business Development

Nqso (Right to Buy)

Derivative security · not the ordinary share price.

Value context: Not a separate purchase
Exercise / conversion price: $162.60 exercise / conversion price

Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Award disclosed

Matthew C. Busch

VP, Finance & CAO

Common Stock

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Award disclosed

Omar Ishrak

Director

Common Stock

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Award disclosed

Charles M. Holley

Director

Common Stock

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Award disclosed

Michael V. Drake

Director

Common Stock

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Exercise or conversion

Derek Miller

SVP, Human Resources

Common Stock

Value context: $336.42K
Reported price: $162.60 / share

Exercise or conversion

Derek Miller

SVP, Human Resources

Common Stock

Value context: $323.15K
Reported price: $177.46 / share

Exercise or conversion

Derek Miller

SVP, Human Resources

Nqso (Right to Buy)

Derivative security · not the ordinary share price.

Value context: Not a separate purchase
Exercise / conversion price: $162.60 exercise / conversion price

Understand this price

Exercise or conversion

Derek Miller

SVP, Human Resources

Nqso (Right to Buy)

Derivative security · not the ordinary share price.

Value context: Not a separate purchase
Exercise / conversion price: $177.46 exercise / conversion price

Understand this price

Exercise or conversion

Nancy A. Grygiel

SVP & CCO

Common Stock

Value context: $349.6K
Reported price: $177.46 / share

Exercise or conversion

Nancy A. Grygiel

SVP & CCO

Common Stock

Value context: $177.31K
Reported price: $177.31 / share

Exercise or conversion

Nancy A. Grygiel

SVP & CCO

Nqso (Right to Buy)

Derivative security · not the ordinary share price.

Value context: Not a separate purchase
Exercise / conversion price: $177.46 exercise / conversion price

Understand this price

Exercise or conversion

Nancy A. Grygiel

SVP & CCO

Nqso (Right to Buy)

Derivative security · not the ordinary share price.

Value context: Not a separate purchase
Exercise / conversion price: $177.31 exercise / conversion price

Understand this price

Award disclosed

Amy E. Miles

Director

Common Stock

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Award disclosed

Ellen Jamison Kullman

Director

Common Stock

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Award disclosed

Mary E. Klotman

Director

Common Stock

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Award disclosed

Tyler Jacks

Director

Common Stock

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Award disclosed

Omar Ishrak

Director

Common Stock

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Award disclosed

Charles M. Holley

Director

Common Stock

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Reporting insider	Security / transaction	Amount / price	Value	Traded / disclosed	Source
SVP, Business Development	Common StockOption exercise or conversion	1,252$162.60 / share	$203.58K	Aug 13Filed Aug 13 · 0d later	SEC filing
SVP, Business Development	Nqso (Right to Buy)Option exercise or conversion	Derivative units1,252$162.60 exercise / conversion price	Not a separate purchase	Aug 13Filed Aug 13 · 0d later	SEC filing
VP, Finance & CAO	Common StockGrant or award	730Award · no purchase price	Non-cash award	Aug 7Filed Aug 12 · 5d later	SEC filing
Director	Common StockGrant or award	85Award · no purchase price	Non-cash award	Aug 7Filed Aug 10 · 3d later	SEC filing
Director	Common StockGrant or award	103Award · no purchase price	Non-cash award	Aug 7Filed Aug 10 · 3d later	SEC filing
Director	Common StockGrant or award	64Award · no purchase price	Non-cash award	Aug 7Filed Aug 10 · 3d later	SEC filing
SVP, Human Resources	Common StockOption exercise or conversion	2,069$162.60 / share	$336.42K	Aug 6Filed Aug 7 · 1d later	SEC filing
SVP, Human Resources	Common StockOption exercise or conversion	1,821$177.46 / share	$323.15K	Aug 6Filed Aug 7 · 1d later	SEC filing
SVP, Human Resources	Nqso (Right to Buy)Option exercise or conversion	Derivative units2,069$162.60 exercise / conversion price	Not a separate purchase	Aug 6Filed Aug 7 · 1d later	SEC filing
SVP, Human Resources	Nqso (Right to Buy)Option exercise or conversion	Derivative units1,821$177.46 exercise / conversion price	Not a separate purchase	Aug 6Filed Aug 7 · 1d later	SEC filing
SVP & CCO	Common StockOption exercise or conversion	1,970$177.46 / share	$349.6K	Aug 6Filed Aug 7 · 1d later	SEC filing
SVP & CCO	Common StockOption exercise or conversion	1,000$177.31 / share	$177.31K	Aug 6Filed Aug 7 · 1d later	SEC filing
SVP & CCO	Nqso (Right to Buy)Option exercise or conversion	Derivative units1,970$177.46 exercise / conversion price	Not a separate purchase	Aug 6Filed Aug 7 · 1d later	SEC filing
SVP & CCO	Nqso (Right to Buy)Option exercise or conversion	Derivative units1,000$177.31 exercise / conversion price	Not a separate purchase	Aug 6Filed Aug 7 · 1d later	SEC filing
Director	Common StockGrant or award	665Award · no purchase price	Non-cash award	May 19Filed May 21 · 2d later	SEC filing
Director	Common StockGrant or award	665Award · no purchase price	Non-cash award	May 19Filed May 21 · 2d later	SEC filing
Director	Common StockGrant or award	665Award · no purchase price	Non-cash award	May 19Filed May 21 · 2d later	SEC filing
Director	Common StockGrant or award	665Award · no purchase price	Non-cash award	May 19Filed May 21 · 2d later	SEC filing
Director	Common StockGrant or award	665Award · no purchase price	Non-cash award	May 19Filed May 21 · 2d later	SEC filing
Director	Common StockGrant or award	665Award · no purchase price	Non-cash award	May 19Filed May 21 · 2d later	SEC filing

Showing the latest 20 of 92 trades. Show all 92 trades

Congress transactions 19

All Congress filings

Purchase disclosed

Amgen Inc. - Common Stock (AMGN) · Stock

The filing reports a purchase for the member.

David J. TaylorReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: September 22, 2026

Sale disclosed

Amgen Inc. - Common Stock (AMGN) · Stock

The filing reports a sale for the member.

David J. TaylorReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: August 26, 2026

Sale disclosed

Amgen Inc. - Common Stock (AMGN) · Stock

The filing reports a sale for the member.

David J. TaylorReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: August 26, 2026

Partial sale disclosed

Amgen Inc. - Common Stock · Stock

The filing reports a partial sale for a spouse.

Sheldon WhitehouseReporting Senate member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: August 12, 2026

Full sale disclosedAmended report

Amgen Inc · Stock

The filing reports a full sale for a joint account.

Thomas H TubervilleReporting Senate member

Reported amount: $15,001 – $50,000Reported range; exact amount not disclosed.
Trade date: April 15, 2025

Full sale disclosed

Amgen Inc. - Common Stock · Stock

The filing reports a full sale for the member.

AAAlan ArmstrongReporting Senate member

Reported amount: $15,001 – $50,000Reported range; exact amount not disclosed.
Trade date: March 27, 2026

Purchase disclosed

Amgen Inc. - Common Stock (AMGN) · Stock

The filing reports a purchase for the member.

David J. TaylorReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: June 5, 2026

Sale disclosed

Amgen Inc. - Common Stock (AMGN) · Stock

The filing reports a sale for the member.

Maria Elvira SalazarReporting House member

Reported amount: $15,001 – $50,000Reported range; exact amount not disclosed.
Trade date: April 17, 2026

Purchase disclosed

Amgen Inc. - Common Stock (AMGN) · Stock

The filing reports a purchase for the member.

Maria Elvira SalazarReporting House member

Reported amount: $15,001 – $50,000Reported range; exact amount not disclosed.
Trade date: March 24, 2026

Sale disclosed

Amgen Inc. - Common Stock (AMGN) · Stock

The filing reports a sale for the member.

David J. TaylorReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: February 26, 2026

Sale disclosed

Amgen Inc. - Common Stock (AMGN) · Stock

The filing reports a sale for the member.

David J. TaylorReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: January 29, 2026

Purchase disclosed

Amgen Inc. - Common Stock (AMGN) · Stock

The filing reports a purchase for the member.

David J. TaylorReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: January 16, 2026

Sale disclosed

Amgen Inc. - Common Stock (AMGN) · Stock

The filing reports a sale for the member.

Julia LetlowReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: November 19, 2024

Purchase disclosed

Amgen Inc. - Common Stock (AMGN) · Stock

The filing reports a purchase for the member.

Julia LetlowReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: October 23, 2024

Sale disclosed

Amgen Inc. - Common Stock (AMGN) · Stock

The filing reports a sale for the member.

David J. TaylorReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: December 3, 2025

Sale disclosed

Amgen Inc. - Common Stock (AMGN) · Stock

The filing reports a sale for the member.

David J. TaylorReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: December 3, 2025

Purchase disclosed

Amgen Inc. - Common Stock (AMGN) · Stock

The filing reports a purchase for the member.

Marjorie Taylor Greene official portrait

Marjorie Taylor GreeneReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: October 24, 2025

Sale disclosed

Amgen Inc. - Common Stock (AMGN) · Stock

The filing reports a sale for a spouse.

Lisa McClainReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: September 25, 2025

Purchase disclosed

Amgen Inc. - Common Stock (AMGN) · Stock

The filing reports a purchase for the member.

Marjorie Taylor GreeneReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: September 11, 2025

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage

Source: SEC EDGAR · Form 4
Issuer CIK: 0000318154
Latest public acceptance: Aug 13, 2026, 11:05 PM UTC
Score calculated: Oct 7, 2026, 12:04 AM UTC
Parser: form4-parser-1.5
Classifier: form4-classifier-1.1
Scoring methodology: insider-experimental-1.1
Availability: Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.

Reporting insider

Security / transaction

Amount / price

Value

Traded / disclosed

Source

SVP, Business Development

Common StockOption exercise or conversion

1,252$162.60 / share

$203.58K

Aug 13Filed Aug 13 · 0d later

SEC filing

SVP, Business Development

Nqso (Right to Buy)Option exercise or conversion

Derivative units1,252$162.60 exercise / conversion price

Not a separate purchase

Aug 13Filed Aug 13 · 0d later

SEC filing

VP, Finance & CAO

Common StockGrant or award

730Award · no purchase price

Non-cash award

Aug 7Filed Aug 12 · 5d later

SEC filing

Director

Common StockGrant or award

85Award · no purchase price

Non-cash award

Aug 7Filed Aug 10 · 3d later

SEC filing

Director

Common StockGrant or award

103Award · no purchase price

Non-cash award

Aug 7Filed Aug 10 · 3d later

SEC filing

Director

Common StockGrant or award

64Award · no purchase price

Non-cash award

Aug 7Filed Aug 10 · 3d later

SEC filing

SVP, Human Resources

Common StockOption exercise or conversion

2,069$162.60 / share

$336.42K

Aug 6Filed Aug 7 · 1d later

SEC filing

SVP, Human Resources

Common StockOption exercise or conversion

1,821$177.46 / share

$323.15K

Aug 6Filed Aug 7 · 1d later

SEC filing

SVP, Human Resources

Nqso (Right to Buy)Option exercise or conversion

Derivative units2,069$162.60 exercise / conversion price

Not a separate purchase

Aug 6Filed Aug 7 · 1d later

SEC filing

SVP, Human Resources

Nqso (Right to Buy)Option exercise or conversion

Derivative units1,821$177.46 exercise / conversion price

Not a separate purchase

Aug 6Filed Aug 7 · 1d later

SEC filing

SVP & CCO

Common StockOption exercise or conversion

1,970$177.46 / share

$349.6K

Aug 6Filed Aug 7 · 1d later

SEC filing

SVP & CCO

Common StockOption exercise or conversion

1,000$177.31 / share

$177.31K

Aug 6Filed Aug 7 · 1d later

SEC filing

SVP & CCO

Nqso (Right to Buy)Option exercise or conversion

Derivative units1,970$177.46 exercise / conversion price

Not a separate purchase

Aug 6Filed Aug 7 · 1d later

SEC filing

SVP & CCO

Nqso (Right to Buy)Option exercise or conversion

Derivative units1,000$177.31 exercise / conversion price

Not a separate purchase

Aug 6Filed Aug 7 · 1d later

SEC filing

Director

Common StockGrant or award

665Award · no purchase price

Non-cash award

May 19Filed May 21 · 2d later

SEC filing

Director

Common StockGrant or award

665Award · no purchase price

Non-cash award

May 19Filed May 21 · 2d later

SEC filing

Director

Common StockGrant or award

665Award · no purchase price

Non-cash award

May 19Filed May 21 · 2d later

SEC filing

Director

Common StockGrant or award

665Award · no purchase price

Non-cash award

May 19Filed May 21 · 2d later

SEC filing

Director

Common StockGrant or award

665Award · no purchase price

Non-cash award

May 19Filed May 21 · 2d later

SEC filing

Director

Common StockGrant or award

665Award · no purchase price

Non-cash award

May 19Filed May 21 · 2d later

SEC filing

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage

Source: SEC EDGAR · Form 4
Issuer CIK: 0000318154
Latest public acceptance: Aug 13, 2026, 11:05 PM UTC
Score calculated: Oct 7, 2026, 12:04 AM UTC
Parser: form4-parser-1.5
Classifier: form4-classifier-1.1
Scoring methodology: insider-experimental-1.1
Availability: Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.